- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
19 result(s) found for: Maxillary sinus.
Displaying page 1 of 1.
EudraCT Number: 2004-001460-42 | Sponsor Protocol Number: HMR 3647A/4023 | Start Date*: 2004-11-16 | |||||||||||
Sponsor Name:Aventis Intercontinental - Sanofi-aventis | |||||||||||||
Full Title: A prospective, randomized, open-label, active-controlled study in adult subjects with acute bacterial sinusitis comparing the clinical efficacy of telithromycin (KETEK®) 800 mg once a day for 5 da... | |||||||||||||
Medical condition: acute bacterial sinusitis (ABS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000639-13 | Sponsor Protocol Number: A0661142 | Start Date*: 2005-10-10 | |||||||||||
Sponsor Name:Pfizer Ltd | |||||||||||||
Full Title: An open-label, multi-center trial of azithromycin pharmacokinetics in sinus aspirate and serum following oral administration of either a 500 mg immediate-release (IR) once-daily 3 day regimen or a ... | |||||||||||||
Medical condition: Acute bacterial sinusitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) SE (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005374-26 | Sponsor Protocol Number: ECAELEV21 | Start Date*: 2022-08-18 |
Sponsor Name:OMEQUI coordinator | ||
Full Title: Efficacy of platelet- and leukocyte-rich fibrin (L-PRF) in reducing healing time in sinus lift combined with deproteinized bovine mineralized bone (DBBM): randomized clinical trial. | ||
Medical condition: If the application of L-PRF with respect to the use of DBBM shows that there are differences in the percentage of new bone between the LPRF group and the control group at 4 and 6 months | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004925-42 | Sponsor Protocol Number: P04824 | Start Date*: 2015-04-13 |
Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation | ||
Full Title: Efficacy and Safety of 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) vs Placebo as Adjunctive Treatment to Antibiotics in Relief of Symptoms of Acute Bacterial Sinusitis | ||
Medical condition: Acute Bacterial Sinusitis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2021-001885-40 | Sponsor Protocol Number: Syst-AB+Sinus | Start Date*: 2022-02-24 |
Sponsor Name:Universidad Complutense de Madrid | ||
Full Title: The effect of systemic antibiotics on post-surgical complications and paitent-centered outomes in patients undergoing implant surgery with the guided bone regeneration and simultaneous sinus floor ... | ||
Medical condition: The medical condition that the patients have in this trial is edentulism in a posterior maxillary quadrant of the mouth with a sinus pneumatisation/ decreased crestal bone heigh defect requiring a... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003391-37 | Sponsor Protocol Number: Scil-MD05-C01 | Start Date*: 2005-12-05 | |||||||||||
Sponsor Name:Scil Technology GmbH | |||||||||||||
Full Title: Pilot Study on Safety and explorative Efficacy of MD05 in Comparison with the Medical Device Beta-TCP Mixed with Autogenous Bone Material in Patients Undergoing Two-Stage Unilateral Maxillary Sinus... | |||||||||||||
Medical condition: Requirement of two-stage unilateral maxillary sinus floor augmentation in case of insufficient bone height in the area of the posterior maxilla, prior to insertion of dental implants. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022188-37 | Sponsor Protocol Number: 29072010 | Start Date*: 2010-11-29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Pirkanmaan sairaanhoitopiiri | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A comparative study between the Relieva Stratus MicroFlow Spacer drug eluting ethmoid sinus stent therapy and the intranasal corticoid steroid therapy in the treatment of patients with chronic rhin... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Kaikki tutkittavat henkilöt niin lääkeimplantti- kuin nenäsumuteverrokkiryhmässä sairastavat kroonista sinuiittia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002955-33 | Sponsor Protocol Number: 027SC10363 | Start Date*: 2012-02-16 |
Sponsor Name:Aziende Chimiche Riunite Angelini Francesco S.p.A | ||
Full Title: Clinical and microbiological assessment of prulifloxacin in patients with Acute Bacterial Rhinosinusitis (ABRS) | ||
Medical condition: Male or female adults with ABRS, defined as the presence of 2 (including at least one between nasal blockage/congestion/ obstruction or nasal discharge) or more of the following signs and symptoms:... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: RO (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-000368-12 | Sponsor Protocol Number: OPN-FLU-CS-3205 | Start Date*: 2019-10-01 | |||||||||||
Sponsor Name:OptiNose US, Inc. | |||||||||||||
Full Title: A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 μg of OPN-375 Twice a Day (... | |||||||||||||
Medical condition: Chronic sinusitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004907-22 | Sponsor Protocol Number: AUG117150 | Start Date*: 2016-08-03 |
Sponsor Name:Medicines Development (Infectious Diseases) | ||
Full Title: A multicenter, open-label study to assess the efficacy and safety of potassium clavulanate/amoxicillin (CVA/AMPC 1:14 combination) in the treatment of [Japanese] children with acute bacterial rhin... | ||
Medical condition: Acute Bacterial Rhinosinusitis | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2008-007877-19 | Sponsor Protocol Number: colistin nasal CF pilot | Start Date*: 2009-06-15 | |||||||||||
Sponsor Name:University of Jena | |||||||||||||
Full Title: Nasale Inhalation von Colistin mit dem Pari-Sinus-Vernebler bei Patienten mit Mukoviszidose und Pseudomonasnachweis im Nasen-Nasennebenhöhlenbereich. Nasal inhalation of colistin by the Pari Sinus... | |||||||||||||
Medical condition: subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002340-42 | Sponsor Protocol Number: SBG-2-03 | Start Date*: 2008-09-16 | |||||||||||
Sponsor Name:Biotec Pharmacon ASA | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel-group phase III clinical study to assess the efficacy and safety of soluble beta 1,3/1,6 glucan (SBG) on oral mucositis in head and neck can... | |||||||||||||
Medical condition: Oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004621-89 | Sponsor Protocol Number: LYR-210-2018-002 | Start Date*: 2019-07-29 | |||||||||||
Sponsor Name:Lyra Therapeutics, Inc. | |||||||||||||
Full Title: A Phase II, Randomized, Blinded, Sham Procedure-Controlled, Parallel-Group Trial to Evaluate the Efficacy, Safety and Tolerability of LYR-210 in Adult Subjects with Chronic Sinusitis (LANTERN Study) | |||||||||||||
Medical condition: Chronic sinusitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000648-86 | Sponsor Protocol Number: OPN-FLU-CS-3206 | Start Date*: 2019-10-01 | |||||||||||
Sponsor Name:OptiNose US, Inc. | |||||||||||||
Full Title: A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 μg of OPN-375 Twice a Day (B... | |||||||||||||
Medical condition: Chronic rhinosinusitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) CZ (Completed) PL (Completed) ES (Ongoing) BG (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005565-54 | Sponsor Protocol Number: SBG-2-04 | Start Date*: 2008-12-08 | |||||||||||
Sponsor Name:Biotec Pharmacon ASA | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel-group phase III clinical study to assess the efficacy and safety of soluble beta 1,3/1,6 glucan (SBG) on oral mucositis in head and neck can... | |||||||||||||
Medical condition: Oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001227-13 | Sponsor Protocol Number: SOPAZITHRO | Start Date*: 2022-02-22 | ||||||||||||||||
Sponsor Name:Centre hospitalier intercommunal de Créteil | ||||||||||||||||||
Full Title: Evaluation of the Efficacy of 3-month Continuous Extended Treatment With Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults: a Multicentre Randomised Controlled Trial | ||||||||||||||||||
Medical condition: Patients with Purulent Oedematous Sinusitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000585-15 | Sponsor Protocol Number: CBP-201-WW003 | Start Date*: 2021-11-11 | |||||||||||
Sponsor Name:Suzhou Connect Biopharmaceuticals Ltd. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate CBP-201 in Adult Patients with Chronic Rhinosinusitis with Nasal Polyps | |||||||||||||
Medical condition: Chronic Rhinosinusitis with Nasal Polyps | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001153-27 | Sponsor Protocol Number: PenVe | Start Date*: 2019-02-22 | |||||||||||||||||||||
Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | |||||||||||||||||||||||
Full Title: A feasibility study of a prospective randomised controlled trial comparing the use of open label pentoxifylline and tocopherol versus current standard of care for the prevention of fibrosis related... | |||||||||||||||||||||||
Medical condition: Osteoradionecrosis, trismus and dysphagia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000075-33 | Sponsor Protocol Number: SINTART1 | Start Date*: 2013-05-04 | |||||||||||
Sponsor Name:Fondazione IRCCS Istituto Nazionale Tumori | |||||||||||||
Full Title: Multidisciplinary approach for poor prognosis sinonasal tumors: Phase II study of chemotherapy, surgery, photon and heavy ion radiotherapy integration for more effective and less toxic treatment in... | |||||||||||||
Medical condition: Poor prognosis sinonasal tumors in operable patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
